Ketoprofen: Non-alcoholic fatty liver disease and steatohepatitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1348-1349, 2011-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Levels of the Oxidative Stress Marker γ-Glutamyltranspeptidase at Different Stages of Nonalcoholic Fatty Liver Disease

By Irie M   Sohda T   Iwata K   Kunimoto H   Fukunaga A   Kuno S   Yotsumoto K   Sakurai K   Iwashita H   Hirano G   Ueda SI   Yokoyama K   Morihara D   Nishizawa S   Anan A   Takeyama Y   Sakamoto M   Shakado S   Sakisaka S  

The Journal of International Medical Research, Vol. 40, Iss. 3, 2012-05 ,pp. : 924-933

Field House Publishing

Access to resources Recommend Favorite

Nonalcoholic fatty liver disease: a review

By Poordad F Fred  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 3, 2005-08 ,pp. : 661-670

Informa Healthcare

Access to resources Recommend Favorite

Nonalcoholic fatty liver disease in children and adolescents – Relationship with Polycystic Ovary Syndrome

By  

Current Pharmaceutical Design, Vol. 21, Iss. 35, 2015-10 ,pp. : 5144-5150

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms Involved in the Protective Effects of Metformin Against Nonalcoholic Fatty Liver Disease

By  

Current Medicinal Chemistry, Vol. 19, Iss. 18, 2012-06 ,pp. : 2918-2923

Bentham Science Publishers

Access to resources Recommend Favorite